Javascript er ikke aktivert i din nettleser. Dette er nødvendig for å bruke Oncolex. Kontakt din systemadministrator for å aktivere JavaScript.

Treatment of Acute Myeloid Leukemia


High-dose cytarabine is standard treatment for patients < 60 years and is administered as four repeated courses with 4 week intervals.

Alternative treatment protocols including high dose treatment with autologous stem cell support have not, so far, been shown to give better results.

Oslo University Hospital shall not be liable for any loss whether direct, indirect, incidental or consequential, arising out of access to, use of, or reliance upon any of the content on this website. Oslo University Hospital© 2018